The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial).
Poordad F, Rustgi V, Brown RS Jr, Patel V, Kugelmas M, Regenstein F, Balart L, LaBrecque D, Brown K, Avila M, Biederman M, Freed G, Smith R, Bernstein M, Arnold H, Cahan J, Fink S, Katkov W, Massoumi H, Harrison S.
Poordad F, et al.
Therap Adv Gastroenterol. 2015 Sep;8(5):263-9. doi: 10.1177/1756283X15588876.
Therap Adv Gastroenterol. 2015.
PMID: 26327916
Free PMC article.